Featured News
706NewsOnline Learning Help for the Public Sector from eCom
Dunfermline, United Kingdom, February 13, 2021 –(PR.com)– eCom, Scotland’s leading digital learning and assessment specialists, are launching an initiative to help public...
- 716Wire Stories
Alchemy Partners Instpower to Enable Crypto Payments Across Global Network of Power Bank Sharing Stations
SINGAPORE–(BUSINESS WIRE)–Alchemy Pay, the world’s first decentralized finance (DeFi) hybrid fiat and crypto payment solution provider, has partnered with Instpower, a global...
- 650Wire Stories
SBB Research Group Names Three Chicago Nonprofits as February 2021 Grant Finalists
CHICAGO–(BUSINESS WIRE)–SBB Research Group LLC is pleased to announce three Chicago-area charities as the February 2021 finalists of its monthly grant program...
- 642News
CS Odessa Announces New Project Management Solution
A new addition to the Project Management Area of ConceptDraw Solutions makes it easy for anyone to build and present any professional...
- 651News
Mechatronics Becomes a Universal Provider for Fuel Monitoring Projects
GPS tracking companies are always looking for a hardware supplier with a full range of sensors catering to various projects. Especially if...
- 755Wire Stories
Royal Farms Offering Employees Wellness Bonus for Vaccination
BALTIMORE, Md., Feb. 12, 2021 (GLOBE NEWSWIRE) — Royal Farms today announced it will pay a $50 wellness bonus to each employee...
- 669Wire Stories
YFDAI Concludes First Governance Vote to Introduce New SST Token and NFTs
SINGAPORE–(BUSINESS WIRE)–YFDAI Finance, a permissionless decentralized finance (DeFi) ecosystem, has officially announced the results of their first community governance vote, which resulted...
- 692Wire Stories
Seagen and Astellas Announce Presentation of Results from PADCEV® (enfortumab vedotin-ejfv) Pivotal Trial in Patients with Previously Treated Advanced Urothelial Cancer Who Were Ineligible for Cisplatin Chemotherapy
– Durable Tumor Responses Experienced Among Patients Previously Treated with Immunotherapy in Second Cohort of EV-201 Trial – – Data Presented in...
- 798Wire Stories
Seagen and Astellas Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV® (enfortumab vedotin-ejfv) in Patients with Previously Treated Advanced Urothelial Cancer
– Findings from the EV-301 Trial Showed Significant Improvements in Overall Survival and Progression-Free Survival Compared to Chemotherapy – – EV-301 Intended...
- 709News
Mark Mccormick Tech Entrepreneur of Mark Mccormick Ltd. Digs Deep to Provide Much Needed Financial Support
Mark McCormick, a Tech Entrepreneur from Ireland, today reveals a €50m Competitive Start-Up Fund. Dublin, Ireland, February 12, 2021 –(PR.com)– Entrepreneurs and...
- 1.1KWire Stories
No Dogs Left Behind Meat Market Survivors Coming Home
29 adopted dogs will be flying into LAX February 13th, then heading to JFK Media is invited to attend both events Funds...
